Stryker Co. (NYSE:SYK) Shares Bought by F M Investments LLC

F M Investments LLC increased its position in shares of Stryker Co. (NYSE:SYK) by 17.7% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 27,801 shares of the medical technology company’s stock after buying an additional 4,188 shares during the period. F M Investments LLC’s holdings in Stryker were worth $10,010,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently bought and sold shares of SYK. DRW Securities LLC acquired a new stake in shares of Stryker in the 4th quarter worth about $256,000. APG Asset Management US Inc. acquired a new position in shares of Stryker in the fourth quarter worth about $2,552,000. Azimuth Capital Investment Management LLC raised its stake in Stryker by 1.0% during the 4th quarter. Azimuth Capital Investment Management LLC now owns 95,402 shares of the medical technology company’s stock valued at $34,350,000 after purchasing an additional 927 shares during the period. Faithward Advisors LLC boosted its holdings in shares of Stryker by 13.1% during the fourth quarter. Faithward Advisors LLC now owns 1,795 shares of the medical technology company’s stock worth $646,000 after purchasing an additional 208 shares during the period. Finally, APG Asset Management N.V. grew its holdings in shares of Stryker by 1,695.0% during the 4th quarter. APG Asset Management N.V. now owns 370,226 shares of the medical technology company’s stock valued at $128,730,000 after acquiring an additional 349,601 shares in the last quarter. 77.09% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several research analysts have recently commented on the stock. Wells Fargo & Company increased their price target on shares of Stryker from $427.00 to $435.00 and gave the stock an “overweight” rating in a research note on Wednesday, January 29th. Citigroup reissued a “buy” rating and issued a $450.00 price objective on shares of Stryker in a research note on Wednesday, February 26th. StockNews.com cut Stryker from a “buy” rating to a “hold” rating in a research report on Thursday, March 6th. Stifel Nicolaus upped their price objective on shares of Stryker from $400.00 to $440.00 and gave the stock a “buy” rating in a report on Wednesday, January 29th. Finally, Canaccord Genuity Group lifted their target price on shares of Stryker from $420.00 to $435.00 and gave the stock a “buy” rating in a report on Wednesday, January 29th. Five analysts have rated the stock with a hold rating and sixteen have given a buy rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $421.90.

Insider Buying and Selling

In other Stryker news, Director Allan C. Golston sold 2,458 shares of the firm’s stock in a transaction on Tuesday, February 18th. The shares were sold at an average price of $383.07, for a total value of $941,586.06. Following the sale, the director now owns 14,895 shares of the company’s stock, valued at $5,705,827.65. This trade represents a 14.16 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Ronda E. Stryker sold 201,392 shares of the business’s stock in a transaction dated Friday, January 31st. The shares were sold at an average price of $392.24, for a total transaction of $78,993,998.08. Following the transaction, the director now owns 3,642,075 shares in the company, valued at $1,428,567,498. This represents a 5.24 % decrease in their position. The disclosure for this sale can be found here. 5.90% of the stock is owned by company insiders.

Stryker Stock Performance

Shares of Stryker stock opened at $363.44 on Thursday. Stryker Co. has a one year low of $314.93 and a one year high of $406.19. The business has a 50-day simple moving average of $377.27 and a 200 day simple moving average of $373.71. The company has a debt-to-equity ratio of 0.59, a current ratio of 1.95 and a quick ratio of 1.32. The firm has a market capitalization of $138.72 billion, a price-to-earnings ratio of 46.84, a PEG ratio of 2.93 and a beta of 0.93.

Stryker (NYSE:SYK) last issued its quarterly earnings results on Tuesday, January 28th. The medical technology company reported $4.01 EPS for the quarter, beating analysts’ consensus estimates of $3.87 by $0.14. Stryker had a return on equity of 23.58% and a net margin of 13.25%. During the same quarter in the prior year, the business earned $3.46 earnings per share. On average, research analysts anticipate that Stryker Co. will post 13.47 earnings per share for the current fiscal year.

Stryker Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Wednesday, April 30th. Stockholders of record on Monday, March 31st will be given a dividend of $0.84 per share. The ex-dividend date of this dividend is Monday, March 31st. This represents a $3.36 dividend on an annualized basis and a dividend yield of 0.92%. Stryker’s dividend payout ratio (DPR) is currently 43.30%.

Stryker Profile

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.